[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global PCR and NGS-Based Molecular Diagnostics Market Growth (Status and Outlook) 2024-2030

March 2024 | 113 pages | ID: G241327907A0EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global PCR and NGS-Based Molecular Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the PCR and NGS-Based Molecular Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global PCR and NGS-Based Molecular Diagnostics market. PCR and NGS-Based Molecular Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of PCR and NGS-Based Molecular Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the PCR and NGS-Based Molecular Diagnostics market.

Key Features:

The report on PCR and NGS-Based Molecular Diagnostics market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the PCR and NGS-Based Molecular Diagnostics market. It may include historical data, market segmentation by Type (e.g., Biomarker Discovery, Blood Sample Testig), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the PCR and NGS-Based Molecular Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the PCR and NGS-Based Molecular Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the PCR and NGS-Based Molecular Diagnostics industry. This include advancements in PCR and NGS-Based Molecular Diagnostics technology, PCR and NGS-Based Molecular Diagnostics new entrants, PCR and NGS-Based Molecular Diagnostics new investment, and other innovations that are shaping the future of PCR and NGS-Based Molecular Diagnostics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the PCR and NGS-Based Molecular Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for PCR and NGS-Based Molecular Diagnostics product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the PCR and NGS-Based Molecular Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting PCR and NGS-Based Molecular Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the PCR and NGS-Based Molecular Diagnostics market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the PCR and NGS-Based Molecular Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the PCR and NGS-Based Molecular Diagnostics market.

Market Segmentation:

PCR and NGS-Based Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Biomarker Discovery
  • Blood Sample Testig
  • Others
Segmentation by application
  • Hospitals
  • Academics/Research Institutions
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Thermofisher
  • Illumine
  • Paragon Genomics
  • Roche
  • Qiagen
  • Bioo Scientific
  • Agilent
  • Pillar Biosciences
  • LC-Bio Technologies (Hangzhou) CO. LTD.
  • iGen Technologies
  • Burning Rock
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global PCR and NGS-Based Molecular Diagnostics Market Size 2019-2030
  2.1.2 PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 PCR and NGS-Based Molecular Diagnostics Segment by Type
  2.2.1 Biomarker Discovery
  2.2.2 Blood Sample Testig
  2.2.3 Others
2.3 PCR and NGS-Based Molecular Diagnostics Market Size by Type
  2.3.1 PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2019-2024)
2.4 PCR and NGS-Based Molecular Diagnostics Segment by Application
  2.4.1 Hospitals
  2.4.2 Academics/Research Institutions
  2.4.3 Others
2.5 PCR and NGS-Based Molecular Diagnostics Market Size by Application
  2.5.1 PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2019-2024)

3 PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Players
  3.1.1 Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2019-2024)
  3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global PCR and NGS-Based Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PCR AND NGS-BASED MOLECULAR DIAGNOSTICS BY REGIONS

4.1 PCR and NGS-Based Molecular Diagnostics Market Size by Regions (2019-2024)
4.2 Americas PCR and NGS-Based Molecular Diagnostics Market Size Growth (2019-2024)
4.3 APAC PCR and NGS-Based Molecular Diagnostics Market Size Growth (2019-2024)
4.4 Europe PCR and NGS-Based Molecular Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas PCR and NGS-Based Molecular Diagnostics Market Size by Country (2019-2024)
5.2 Americas PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024)
5.3 Americas PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC PCR and NGS-Based Molecular Diagnostics Market Size by Region (2019-2024)
6.2 APAC PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024)
6.3 APAC PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe PCR and NGS-Based Molecular Diagnostics by Country (2019-2024)
7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024)
7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics by Region (2019-2024)
8.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PCR AND NGS-BASED MOLECULAR DIAGNOSTICS MARKET FORECAST

10.1 Global PCR and NGS-Based Molecular Diagnostics Forecast by Regions (2025-2030)
  10.1.1 Global PCR and NGS-Based Molecular Diagnostics Forecast by Regions (2025-2030)
  10.1.2 Americas PCR and NGS-Based Molecular Diagnostics Forecast
  10.1.3 APAC PCR and NGS-Based Molecular Diagnostics Forecast
  10.1.4 Europe PCR and NGS-Based Molecular Diagnostics Forecast
  10.1.5 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Forecast
10.2 Americas PCR and NGS-Based Molecular Diagnostics Forecast by Country (2025-2030)
  10.2.1 United States PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.2.2 Canada PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.2.3 Mexico PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.2.4 Brazil PCR and NGS-Based Molecular Diagnostics Market Forecast
10.3 APAC PCR and NGS-Based Molecular Diagnostics Forecast by Region (2025-2030)
  10.3.1 China PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.3.2 Japan PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.3.3 Korea PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.3.4 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.3.5 India PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.3.6 Australia PCR and NGS-Based Molecular Diagnostics Market Forecast
10.4 Europe PCR and NGS-Based Molecular Diagnostics Forecast by Country (2025-2030)
  10.4.1 Germany PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.4.2 France PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.4.3 UK PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.4.4 Italy PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.4.5 Russia PCR and NGS-Based Molecular Diagnostics Market Forecast
10.5 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Forecast by Region (2025-2030)
  10.5.1 Egypt PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.5.2 South Africa PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.5.3 Israel PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.5.4 Turkey PCR and NGS-Based Molecular Diagnostics Market Forecast
  10.5.5 GCC Countries PCR and NGS-Based Molecular Diagnostics Market Forecast
10.6 Global PCR and NGS-Based Molecular Diagnostics Forecast by Type (2025-2030)
10.7 Global PCR and NGS-Based Molecular Diagnostics Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Thermofisher
  11.1.1 Thermofisher Company Information
  11.1.2 Thermofisher PCR and NGS-Based Molecular Diagnostics Product Offered
  11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Thermofisher Main Business Overview
  11.1.5 Thermofisher Latest Developments
11.2 Illumine
  11.2.1 Illumine Company Information
  11.2.2 Illumine PCR and NGS-Based Molecular Diagnostics Product Offered
  11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Illumine Main Business Overview
  11.2.5 Illumine Latest Developments
11.3 Paragon Genomics
  11.3.1 Paragon Genomics Company Information
  11.3.2 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Offered
  11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Paragon Genomics Main Business Overview
  11.3.5 Paragon Genomics Latest Developments
11.4 Roche
  11.4.1 Roche Company Information
  11.4.2 Roche PCR and NGS-Based Molecular Diagnostics Product Offered
  11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Roche Main Business Overview
  11.4.5 Roche Latest Developments
11.5 Qiagen
  11.5.1 Qiagen Company Information
  11.5.2 Qiagen PCR and NGS-Based Molecular Diagnostics Product Offered
  11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Qiagen Main Business Overview
  11.5.5 Qiagen Latest Developments
11.6 Bioo Scientific
  11.6.1 Bioo Scientific Company Information
  11.6.2 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Offered
  11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Bioo Scientific Main Business Overview
  11.6.5 Bioo Scientific Latest Developments
11.7 Agilent
  11.7.1 Agilent Company Information
  11.7.2 Agilent PCR and NGS-Based Molecular Diagnostics Product Offered
  11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Agilent Main Business Overview
  11.7.5 Agilent Latest Developments
11.8 Pillar Biosciences
  11.8.1 Pillar Biosciences Company Information
  11.8.2 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Offered
  11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Pillar Biosciences Main Business Overview
  11.8.5 Pillar Biosciences Latest Developments
11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
  11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Information
  11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product Offered
  11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Main Business Overview
  11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Latest Developments
11.10 iGen Technologies
  11.10.1 iGen Technologies Company Information
  11.10.2 iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Offered
  11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 iGen Technologies Main Business Overview
  11.10.5 iGen Technologies Latest Developments
11.11 Burning Rock
  11.11.1 Burning Rock Company Information
  11.11.2 Burning Rock PCR and NGS-Based Molecular Diagnostics Product Offered
  11.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Burning Rock Main Business Overview
  11.11.5 Burning Rock Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Biomarker Discovery
Table 3. Major Players of Blood Sample Testig
Table 4. Major Players of Others
Table 5. PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 8. PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 11. Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Player (2019-2024)
Table 13. PCR and NGS-Based Molecular Diagnostics Key Players Head office and Products Offered
Table 14. PCR and NGS-Based Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global PCR and NGS-Based Molecular Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Regions (2019-2024)
Table 19. Global PCR and NGS-Based Molecular Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas PCR and NGS-Based Molecular Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Country (2019-2024)
Table 23. Americas PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 25. Americas PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 27. APAC PCR and NGS-Based Molecular Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Table 29. APAC PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 31. APAC PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 33. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Country (2019-2024)
Table 35. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 37. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of PCR and NGS-Based Molecular Diagnostics
Table 46. Key Market Challenges & Risks of PCR and NGS-Based Molecular Diagnostics
Table 47. Key Industry Trends of PCR and NGS-Based Molecular Diagnostics
Table 48. Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Thermofisher Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 53. Thermofisher PCR and NGS-Based Molecular Diagnostics Product Offered
Table 54. Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Thermofisher Main Business
Table 56. Thermofisher Latest Developments
Table 57. Illumine Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 58. Illumine PCR and NGS-Based Molecular Diagnostics Product Offered
Table 59. Illumine Main Business
Table 60. Illumine PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Illumine Latest Developments
Table 62. Paragon Genomics Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 63. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Offered
Table 64. Paragon Genomics Main Business
Table 65. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Paragon Genomics Latest Developments
Table 67. Roche Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 68. Roche PCR and NGS-Based Molecular Diagnostics Product Offered
Table 69. Roche Main Business
Table 70. Roche PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Roche Latest Developments
Table 72. Qiagen Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 73. Qiagen PCR and NGS-Based Molecular Diagnostics Product Offered
Table 74. Qiagen Main Business
Table 75. Qiagen PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Qiagen Latest Developments
Table 77. Bioo Scientific Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 78. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Offered
Table 79. Bioo Scientific Main Business
Table 80. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Bioo Scientific Latest Developments
Table 82. Agilent Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 83. Agilent PCR and NGS-Based Molecular Diagnostics Product Offered
Table 84. Agilent Main Business
Table 85. Agilent PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Agilent Latest Developments
Table 87. Pillar Biosciences Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 88. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Offered
Table 89. Pillar Biosciences Main Business
Table 90. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Pillar Biosciences Latest Developments
Table 92. LC-Bio Technologies (Hangzhou) CO. LTD. Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 93. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product Offered
Table 94. LC-Bio Technologies (Hangzhou) CO. LTD. Main Business
Table 95. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. LC-Bio Technologies (Hangzhou) CO. LTD. Latest Developments
Table 97. iGen Technologies Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 98. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Offered
Table 99. iGen Technologies Main Business
Table 100. iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. iGen Technologies Latest Developments
Table 102. Burning Rock Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 103. Burning Rock PCR and NGS-Based Molecular Diagnostics Product Offered
Table 104. Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Burning Rock Main Business
Table 106. Burning Rock Latest Developments

LIST OF FIGURES

Figure 1. PCR and NGS-Based Molecular Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. PCR and NGS-Based Molecular Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. PCR and NGS-Based Molecular Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. PCR and NGS-Based Molecular Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type in 2023
Figure 10. PCR and NGS-Based Molecular Diagnostics in Hospitals
Figure 11. Global PCR and NGS-Based Molecular Diagnostics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. PCR and NGS-Based Molecular Diagnostics in Academics/Research Institutions
Figure 13. Global PCR and NGS-Based Molecular Diagnostics Market: Academics/Research Institutions (2019-2024) & ($ Millions)
Figure 14. PCR and NGS-Based Molecular Diagnostics in Others
Figure 15. Global PCR and NGS-Based Molecular Diagnostics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application in 2023
Figure 17. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Player in 2023
Figure 18. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas PCR and NGS-Based Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 20. APAC PCR and NGS-Based Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 21. Europe PCR and NGS-Based Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Americas PCR and NGS-Based Molecular Diagnostics Value Market Share by Country in 2023
Figure 24. United States PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region in 2023
Figure 29. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type in 2023
Figure 30. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application in 2023
Figure 31. China PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Country in 2023
Figure 38. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Figure 39. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Figure 40. Germany PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country PCR and NGS-Based Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 54. APAC PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 55. Europe PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. United States PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Canada PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. China PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Japan PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. Korea PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. India PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Australia PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. Germany PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. France PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. UK PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. Italy PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. Russia PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Spain PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Israel PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries PCR and NGS-Based Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share Forecast by Application (2025-2030)


More Publications